[Alpha Biz=(Chicago) Reporter Kim Jisun] Hahn & Company acquired an additional 6% of Lutronic shares through an open purchase, with its total stake exceeding 90%. As a result, investors are paying keen attention to the possibility of delisting Lutronic.

According to the investment banking (IB) industry on the 10th, 1,640,311 shares applied for the Lutronic 2 public purchase conducted by Hahn & Company from the 17th of last month to the 8th of this month. Initially, Hahn & Company bought all 3,735,471 remaining shares in the market and announced its plan to delist them, but only about 44% participated. The public purchase was led by NH Investment & Securities following the first round.

After acquiring a 19.23 percent stake in Lutronic Chairman Hwang Hae-ryeong, who was the existing largest shareholder, in June, Hahn & Company acquired 63.89 percent more shares through its first public purchase that ended last month. Including the shares collected from the second public purchase, the company has secured a total of 90.17% of Lutronic shares. Including the treasury stocks held by Lutronic, the largest shareholder has a total stake of 93%.

The investment industry is paying attention to whether Hahn & Company will actually apply for delisting on the exchange. In the case of KOSDAQ-listed companies, it is usually believed that if the largest shareholder secures a 90% or more stake, it meets the delisting requirement. Once the stake is secured, the largest shareholder will apply for delisting on the exchange, and the exchange will hold a corporate review committee meeting within a month to decide. Osstem Implants, which were previously publicly purchased twice in January and March this year, are also set to be delisted on the 11th after such procedures.

 

[ⓒ AlphaBIZ. 무단전재-재배포 금지]